1. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection 
Sue J. Goldie, MD, MPH, A.David Paltiel, PhD, Milton C. Weinstein, PhD, Elena Losina, PhD, George R. Seage, ScD, MPH, April D. Kimmel, Rochelle P. Walensky, MD, MPH, Paul E. Sax, MD, Kenneth A. Freedberg, MD, MSc 
The American Journal of Medicine 
Volume 115, Issue 8, Pages (December 2003)
DOI: /j.amjmed

2. Figure 1
Relation between the percentage reduction in failure and percentage of viral suppression in three cohorts.
The American Journal of Medicine  , DOI: ( /j.amjmed )

3. Figure 2
Cost-effectiveness of interventions to improve adherence in an urban cohort. The sensitivity analysis shows the relation among the effectiveness of an intervention, the incremental cost-effectiveness ratio (compared with standard care), and four hypothetical adherence interventions with monthly costs ranging from $50 to $1000.
The American Journal of Medicine  , DOI: ( /j.amjmed )